Two hemophilia patients in the U.S. who struggled for years with bleeds have been given Hemgenix, the first gene therapy ...

Columnist Jennifer Lynne reflects on her most-read columns from last year and why those stories resonated with the hemophilia community.

Columnist Joe MacDonald's son struggled to balance school and hemophilia during his first semester of college. Now, he's better prepared.

Columnist G Shellye Horowitz wasn't surprised to learn she had osteopenia, as her bleeding disorder increases her risk of low ...

Sangamo will regain full rights to giroctocogene fitelparvovec, a gene therapy candidate for hemophilia A, after Pfizer ended ...

The U.S. FDA has approved Alhemo, given as once-daily injections, to help prevent bleeds in patients with hemophilia A or B ...

MacDonald worries about her adult son being complacent when it comes to administering his hemophilia medication.

Columnist Alliah Czarielle says a conversation she had with her husband about manual wheelchairs surprised her.

Hemophilia News Today compiled a summary of the 10 most read hemophilia stories of 2024, with links to the individual items.